GB2230790B - Immunity memory cell suspension and method of preparing same - Google Patents

Immunity memory cell suspension and method of preparing same

Info

Publication number
GB2230790B
GB2230790B GB8908241A GB8908241A GB2230790B GB 2230790 B GB2230790 B GB 2230790B GB 8908241 A GB8908241 A GB 8908241A GB 8908241 A GB8908241 A GB 8908241A GB 2230790 B GB2230790 B GB 2230790B
Authority
GB
United Kingdom
Prior art keywords
memory cell
cell suspension
preparing same
immunity memory
immunity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB8908241A
Other languages
English (en)
Other versions
GB2230790A (en
GB8908241D0 (en
Inventor
Mitsuru Doi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEO RESEARCH Co Ltd
Original Assignee
GEO RESEARCH Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEO RESEARCH Co Ltd filed Critical GEO RESEARCH Co Ltd
Publication of GB8908241D0 publication Critical patent/GB8908241D0/en
Publication of GB2230790A publication Critical patent/GB2230790A/en
Application granted granted Critical
Publication of GB2230790B publication Critical patent/GB2230790B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB8908241A 1988-11-30 1989-04-12 Immunity memory cell suspension and method of preparing same Expired - Fee Related GB2230790B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63300726A JP2639834B2 (ja) 1988-11-30 1988-11-30 免疫記憶細胞懸濁液およびその調製方法
CA000596787A CA1333887C (en) 1988-11-30 1989-04-14 Immunity memory cell suspension and method of preparing same

Publications (3)

Publication Number Publication Date
GB8908241D0 GB8908241D0 (en) 1989-05-24
GB2230790A GB2230790A (en) 1990-10-31
GB2230790B true GB2230790B (en) 1993-04-21

Family

ID=25672621

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8908241A Expired - Fee Related GB2230790B (en) 1988-11-30 1989-04-12 Immunity memory cell suspension and method of preparing same

Country Status (7)

Country Link
JP (1) JP2639834B2 (ja)
AU (1) AU603950B1 (ja)
CA (1) CA1333887C (ja)
CH (1) CH678337A5 (ja)
DE (1) DE3913438A1 (ja)
FR (1) FR2646778B1 (ja)
GB (1) GB2230790B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143508A (en) * 1989-06-29 2000-11-07 Rhone-Poulenc Rorer Pharmaceuticals Inc. Device and process for cell capture and recovery
CA1340565C (en) 1989-06-29 1999-05-25 Thomas B. Okarma Device and process for cell capture and recovery
SE467498B (sv) * 1990-11-20 1992-07-27 Vera Stejskal Foerfarande foer in vitro analys av kvicksilverallergier
DE19925405C2 (de) * 1999-06-02 2003-02-13 Bieger Wilfried W Verfahren zum Nachweis von spezifisch antigenreaktiven Lymphozyten sowie ein Nachweis-Kit zur Durchführung dieses Verfahrens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077571A3 (en) * 1981-10-19 1983-10-12 Ajinomoto Co., Inc. Process for producing a lymphokine
AU1363088A (en) * 1987-03-11 1988-10-10 Children's Hospital Incorporated, The Method for the generation of antigen-specific t cell lines and therapeutic use thereof
JPS63300727A (ja) * 1987-05-29 1988-12-07 古形　勝 健康タワシ

Also Published As

Publication number Publication date
GB2230790A (en) 1990-10-31
CH678337A5 (ja) 1991-08-30
GB8908241D0 (en) 1989-05-24
AU603950B1 (en) 1990-11-29
FR2646778B1 (fr) 1991-08-23
CA1333887C (en) 1995-01-10
FR2646778A1 (fr) 1990-11-16
JP2639834B2 (ja) 1997-08-13
JPH02150274A (ja) 1990-06-08
DE3913438A1 (de) 1990-10-25

Similar Documents

Publication Publication Date Title
US4977016B1 (en) Low permeability fabric and method of making same
EP0341647A3 (en) Non-volatile memory cell and method of producing the same
EP0132979A3 (en) Aqueous atelocollagen solution and method of preparing same
PH22141A (en) N-aralkyl piperidinemethanol derivatives and method of use thereof
GR900300100T1 (en) Spin-bonded all plastic can and method of forming same
IL92751A0 (en) Self-identification of memory system and method
EP0187237A3 (en) Dram cell and method
EP0283924A3 (en) Aqueous suspension and preparation method thereof
EP0335769A3 (en) Electroconducting glass and method of making the same
EP0180026A3 (en) Dram cell and method
ZA892678B (en) Antiperspirant and method of making same
EP0367014A3 (en) Shape memory hollow body and method of working the same
GB2220301B (en) Method of terminating lead filled capacitor and resultant capacitor
GB2223196B (en) Plug receptacle and method of shaping same
GB2230790B (en) Immunity memory cell suspension and method of preparing same
EP0383921A4 (en) Method of preparing nc data
GB2225038B (en) Post support and method of making same
PL270553A1 (en) Method of obtaining high-purity danasol
GB2204313B (en) Novel bisbenzotrifluoride derivatives and method of preparing same
CS495488A1 (en) Hydrophylic copolymer and method of its production
DE3466611D1 (en) Non implanted magnetic bubble memory and its control method
IE883723L (en) Method of enhancing memory with azabicycloalkane¹derivatives
CS3490A2 (en) Elastic amortisseurs and method of their production
EP0377040A4 (en) Postcard and method of preparing same
EP0371136A4 (en) Postcard and method of preparing same

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20050412